ID   MKNK1_HUMAN             Reviewed;         465 AA.
AC   Q9BUB5; O00312; Q5TC06; Q5TC07; Q6V0N6;
DT   30-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   05-OCT-2010, entry version 95.
DE   RecName: Full=MAP kinase-interacting serine/threonine-protein kinase 1;
DE            EC=2.7.11.1;
DE   AltName: Full=MAP kinase signal-integrating kinase 1;
DE            Short=Mnk1;
GN   Name=MKNK1; Synonyms=MNK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), FUNCTION, AND ENZYME
RP   REGULATION.
RC   TISSUE=Cervix carcinoma;
RX   MEDLINE=97299869; PubMed=9155018; DOI=10.1093/emboj/16.8.1921;
RA   Fukunaga R., Hunter T.;
RT   "MNK1, a new MAP kinase-activated protein kinase, isolated by a novel
RT   expression screening method for identifying protein kinase
RT   substrates.";
RL   EMBO J. 16:1921-1933(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, PHOSPHORYLATION AT
RP   THR-250; THR-255 AND THR-385, AND MUTAGENESIS OF LYS-78; ASP-232;
RP   THR-250; THR-255 AND THR-385.
RC   TISSUE=T-cell;
RX   MEDLINE=21356974; PubMed=11463832;
RX   DOI=10.1128/MCB.21.16.5500-5511.2001;
RA   Knauf U., Tschopp C., Gram H.;
RT   "Negative regulation of protein translation by mitogen-activated
RT   protein kinase-interacting kinases 1 and 2.";
RL   Mol. Cell. Biol. 21:5500-5511(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), FUNCTION, TISSUE SPECIFICITY,
RP   PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=15350534; DOI=10.1016/j.yexcr.2004.06.006;
RA   O'Loghlen A., Gonzalez V.M., Pineiro D., Perez-Morgado M.I.,
RA   Salinas M., Martin M.E.;
RT   "Identification and molecular characterization of Mnk1b, a splice
RT   variant of human MAP kinase-interacting kinase Mnk1.";
RL   Exp. Cell Res. 299:343-355(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH EIF4G1 AND EIF4G2.
RX   MEDLINE=99094911; PubMed=9878069; DOI=10.1093/emboj/18.1.270;
RA   Pyronnet S., Imataka H., Gingras A.-C., Fukunaga R., Hunter T.,
RA   Sonenberg N.;
RT   "Human eukaryotic translation initiation factor 4G (eIF4G) recruits
RT   mnk1 to phosphorylate eIF4E.";
RL   EMBO J. 18:270-279(1999).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-460, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-49; VAL-158; ASN-308 AND GLN-446.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May play a role in the response to environmental stress
CC       and cytokines. Appears to regulate transcription by
CC       phosphorylating EIF4E, thus increasing the affinity of this
CC       protein for the 7-methylguanosine-containing mRNA cap.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Magnesium.
CC   -!- ENZYME REGULATION: Phosphorylated and activated by the p38 kinases
CC       and kinases in the Erk pathway.
CC   -!- SUBUNIT: Interacts with the C-terminal regions of EIF4G1 and
CC       EIF4G2. Also binds to dephosphorylated ERK1 and ERK2, and to the
CC       p38 kinases.
CC   -!- INTERACTION:
CC       P06730:EIF4E; NbExp=1; IntAct=EBI-73837, EBI-73440;
CC       Q04637:EIF4G1; NbExp=1; IntAct=EBI-73837, EBI-73711;
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Cytoplasm.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Cytoplasm. Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q9BUB5-1; Sequence=Displayed;
CC       Name=2; Synonyms=MNK1a;
CC         IsoId=Q9BUB5-2; Sequence=VSP_007352;
CC       Name=3; Synonyms=MNK1b;
CC         IsoId=Q9BUB5-3; Sequence=VSP_007352, VSP_017515;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- PTM: Dual phosphorylation of Thr-250 and Thr-255 activates the
CC       kinase. Phosphorylation of Thr-385 activates the kinase.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB000409; BAA19885.1; -; mRNA.
DR   EMBL; AY355461; AAQ84219.1; -; mRNA.
DR   EMBL; AL136373; CAI14764.1; -; Genomic_DNA.
DR   EMBL; AL136373; CAI14765.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06904.1; -; Genomic_DNA.
DR   EMBL; BC002755; AAH02755.1; -; mRNA.
DR   IPI; IPI00187091; -.
DR   IPI; IPI00304048; -.
DR   IPI; IPI00412417; -.
DR   RefSeq; NP_001129025.1; -.
DR   RefSeq; NP_003675.2; -.
DR   RefSeq; NP_945324.1; -.
DR   UniGene; Hs.371594; -.
DR   PDB; 2HW6; X-ray; 2.50 A; A/B=37-382.
DR   PDBsum; 2HW6; -.
DR   ProteinModelPortal; Q9BUB5; -.
DR   IntAct; Q9BUB5; 4.
DR   MINT; MINT-85533; -.
DR   STRING; Q9BUB5; -.
DR   PhosphoSite; Q9BUB5; -.
DR   PRIDE; Q9BUB5; -.
DR   Ensembl; ENST00000371946; ENSP00000361014; ENSG00000079277.
DR   GeneID; 8569; -.
DR   KEGG; hsa:8569; -.
DR   UCSC; uc001cqa.1; human.
DR   UCSC; uc001cqb.1; human.
DR   UCSC; uc001cqc.1; human.
DR   CTD; 8569; -.
DR   GeneCards; GC01M047023; -.
DR   H-InvDB; HIX0000552; -.
DR   HGNC; HGNC:7110; MKNK1.
DR   MIM; 606724; gene.
DR   PharmGKB; PA30829; -.
DR   eggNOG; prNOG07605; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG106949; -.
DR   InParanoid; Q9BUB5; -.
DR   OMA; HEENELA; -.
DR   PhylomeDB; Q9BUB5; -.
DR   BRENDA; 2.7.11.1; 247.
DR   Pathway_Interaction_DB; mtor_4pathway; mTOR signaling pathway.
DR   Pathway_Interaction_DB; p38alphabetadownstreampathway; Signaling mediated by p38-alpha and p38-beta.
DR   NextBio; 32143; -.
DR   ArrayExpress; Q9BUB5; -.
DR   Bgee; Q9BUB5; -.
DR   CleanEx; HS_MKNK1; -.
DR   Genevestigator; Q9BUB5; -.
DR   GermOnline; ENSG00000079277; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0007243; P:intracellular protein kinase cascade; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:UniProtKB.
DR   GO; GO:0006417; P:regulation of translation; IEA:UniProtKB-KW.
DR   GO; GO:0006950; P:response to stress; IEA:InterPro.
DR   InterPro; IPR020636; Ca/CaM-dep_prot_kinase-like.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR015731; MAP_Kinase_interacting_Kinase.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22982; Ca/CaM-dep_prot_kinase-like; 1.
DR   PANTHER; PTHR22982:SF21; MAP_k_interact_k; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Kinase; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Polymorphism; Serine/threonine-protein kinase; Transferase;
KW   Translation regulation.
FT   CHAIN         1    465       MAP kinase-interacting serine/threonine-
FT                                protein kinase 1.
FT                                /FTId=PRO_0000086334.
FT   DOMAIN       49    374       Protein kinase.
FT   NP_BIND      55     63       ATP (By similarity).
FT   ACT_SITE    211    211       Proton acceptor (By similarity).
FT   BINDING      78     78       ATP.
FT   MOD_RES     250    250       Phosphothreonine.
FT   MOD_RES     255    255       Phosphothreonine.
FT   MOD_RES     385    385       Phosphothreonine.
FT   MOD_RES     460    460       Phosphoserine.
FT   VAR_SEQ     165    205       Missing (in isoform 2 and isoform 3).
FT                                /FTId=VSP_007352.
FT   VAR_SEQ     377    465       QAPEKGLPTPQVLQRNSSTMDLTLFAAEAIALNRQLSQHEE
FT                                NELAEEPEALADGLCSMKLSPPCKSRLARRRALAQAGRGED
FT                                RSPPTAL -> EQQHNGPDALRS (in isoform 3).
FT                                /FTId=VSP_017515.
FT   VARIANT      49     49       K -> Q (in dbSNP:rs56351860).
FT                                /FTId=VAR_040801.
FT   VARIANT     158    158       L -> V (in dbSNP:rs56408722).
FT                                /FTId=VAR_040802.
FT   VARIANT     308    308       D -> N (in dbSNP:rs55791614).
FT                                /FTId=VAR_040803.
FT   VARIANT     446    446       R -> Q (in dbSNP:rs34881418).
FT                                /FTId=VAR_040804.
FT   MUTAGEN      78     78       K->M: Loss of kinase activity; when
FT                                associated with D-232.
FT   MUTAGEN     232    232       D->A: Loss of kinase activity; when
FT                                associated with K-78.
FT   MUTAGEN     250    250       T->A: Loss of kinase activity; when
FT                                associated with T-255.
FT   MUTAGEN     255    255       T->A: Loss of kinase activity; when
FT                                associated with T-250.
FT   MUTAGEN     385    385       T->D: Constitutively active.
FT   HELIX        44     46
FT   STRAND       48     57
FT   STRAND       59     68
FT   TURN         69     71
FT   STRAND       74     81
FT   HELIX        87    101
FT   STRAND      110    115
FT   STRAND      117    125
FT   HELIX       132    139
FT   HELIX       144    163
FT   TURN        164    206
FT   HELIX       214    216
FT   STRAND      217    220
FT   STRAND      227    230
FT   STRAND      271    274
FT   HELIX       277    296
FT   HELIX       337    340
FT   HELIX       345    354
FT   TURN        359    361
FT   HELIX       365    370
FT   TURN        372    375
SQ   SEQUENCE   465 AA;  51342 MW;  CAE225C35DCB2B43 CRC64;
     MVSSQKLEKP IEMGSSEPLP IADGDRRRKK KRRGRATDSL PGKFEDMYKL TSELLGEGAY
     AKVQGAVSLQ NGKEYAVKII EKQAGHSRSR VFREVETLYQ CQGNKNILEL IEFFEDDTRF
     YLVFEKLQGG SILAHIQKQK HFNEREASRV VRDVAAALDF LHTKDKVSLC HLGWSAMAPS
     GLTAAPTSLG SSDPPTSASQ VAGTTGIAHR DLKPENILCE SPEKVSPVKI CDFDLGSGMK
     LNNSCTPITT PELTTPCGSA EYMAPEVVEV FTDQATFYDK RCDLWSLGVV LYIMLSGYPP
     FVGHCGADCG WDRGEVCRVC QNKLFESIQE GKYEFPDKDW AHISSEAKDL ISKLLVRDAK
     QRLSAAQVLQ HPWVQGQAPE KGLPTPQVLQ RNSSTMDLTL FAAEAIALNR QLSQHEENEL
     AEEPEALADG LCSMKLSPPC KSRLARRRAL AQAGRGEDRS PPTAL
//
